ARCHIVES

DSMB Recommends Discontinuing Phase III Perifosine Combination Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 3 | March 29, 2013

Download PDF Visit The Full Archive

Related Articles

John Durant Is Chosen “Cancer Fighter of the Year”.

May 17, 2002

Cancer Incidence Rates For Recent Years Too Optimistic, NCI Researchers Find

October 25, 2002

Ford To Resubmit Budget Slash Of $125 Million For NCI

January 3, 1975

Intensive Chemo Equivalent To Transplant For MCL

December 26, 2008

Zytiga Plus Prednisone Shows Improvement in PFS and OS Over Prednisone Alone

June 29, 2012

In Brief: Three More Comprehensive Centers May Be Names; Hawaii, Cleveland, Ohio State Lead List of 10

May 9, 1975